Chronic Plantar Fasciitis Treated with Two Sessions of Radial Extracorporeal Shock Wave Therapy

Ibrahim, Mahmoud; Donatelli, R; Schmitz, Christoph; Hellman, Madeleine; Buxbaum, Frederick

doi:10.3113/fai.2010.0391

Cited by 77 publications

(64 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Longer-term followup data were not sufficient or comparable enough for meta-analysis; however, there have been encouraging results up to 12 months after treatment reported in individual articles. Ibrahim et al [8] found a significant difference in the improvement of VAS heel pain scores at 24 weeks when comparing placebo with ESWT (100% versus 16% success; p \ 0.001) in favor of ESWT. However, there were no other studies with the same outcomes to enable an analysis at this length of followup.…”

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Aqil

Siddiqui

Solan

et al. 2013

Clinical Orthopaedics &Amp; Related Research

110

View full text Add to dashboard Cite

Background Plantar fasciitis is the most common cause of heel pain. It may remain symptomatic despite conservative treatment with orthoses and analgesia. There is conflicting evidence concerning the role of extracorporeal shock wave therapy (ESWT) in the management of this condition. Questions/purposes We investigated whether there was a significant difference in the change of (1) VAS scores and (2) Roles and Maudsley scores from baseline when treated with ESWT and placebo. Specifically we compared overall improvement from baseline composite VAS, reduction in overall VAS pain, success rate of improving overall VAS pain by 60%, success rate of improving VAS pain by 60% when taking first steps, doing daily activities, and during application of a pain pressure meter.Methods MEDLINE, Embase, and CINAHL databases were searched from January 1980 to January 2013 and a double extraction technique was used to obtain relevant studies. Studies had to be prospective randomized controlled trials on adults and must not have used local anesthesia as part of their treatment protocol. Studies must have specifically recruited patients who continued to be symptomatic despite a minimum of 3 months of conservative treatments. All papers were assessed regarding their methodologic quality and a meta-analysis performed. Seven prospective randomized controlled trials were included in this study. There were 369 patients included in the placebo group and 294 in the ESWT group. Results After ESWT, patients had better composite VAS scores (random effects model, standardized mean difference [SMD] = 0.38; 95% CI, 0.05, 0.72; z = 2.27). They also had a greater reduction in their absolute VAS scores compared with placebo (random effects model, SMD = 0.60; 95% CI, 0.34, 0.85; z = 4.64). Greater success of improving heel pain by 60% was observed after ESWT when taking first steps (random effects model, risk ratio [RR] = 1.30; 95% CI, 1.04, 1.62; z = 2.29) and during daily activities (random effects model, RR = 1.44; 95% CI, 1.13, 1.84; z = 2.96). Subjective measurement of pain using a pressure meter similarly favored ESWT (random effects model, RR = 1.37, 95% CI, 1.06, 1.78; z = 2.41). There was a significant difference in the change to

show abstract

Section: Discussionmentioning

confidence: 98%

“…7). Three studies contributed to the assessment [6][7][8]. As the data were not continuous, it was deemed more appropriate to discuss the results of the trials individually.…”

Section: Placebo 23mentioning

confidence: 99%

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Aqil

Siddiqui

Solan

et al. 2013

Clinical Orthopaedics &Amp; Related Research

110

View full text Add to dashboard Cite

show abstract

“…In a study of 50 patients by Ibrahim et al, the patients in the treatment group were administered with a total of 2 sessions one week apart of shock waves at [20]. In the placebo group, the VAS scores were observed to have improved by 15.2% at 4 th weeks, 13.5% at 12 th weeks and 17% at 24 th weeks and the RM scores improved by 6.3%, 16.8% and 16.8% respectively.…”

Section: Discussionmentioning

confidence: 99%

“…Many placebo-controlled clinical studies have been published reporting that ESWT is a successful treatment in the treatment of plantar fasciitis with success rates reaching 94% [5,[10][11][12][13][14][15][16][17]19,20]. However, some researchers have reported that ESWT showed no difference in effect from a placebo in the treatment of plantar fasciitis [6,[21][22][23].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

An Evaluation of the Efficacy of ESWT and Placebo-ESWT Treatment for Chronic Plantar Fasciitis

Aykol¹,

Ersoy²

2016

Med-Science

View full text Add to dashboard Cite

show abstract

Comparison of efficacy of eight treatments for plantar fasciitis: A network meta‐analysis

Lin

2018

Journal Cellular Physiology

View full text Add to dashboard Cite

The objective of this network meta-analysis (NMA) was to assess the pain relief performance of eight different plantar fasciitis therapies, including nonsteroidal anti-inflammatory medications, corticosteroid injections (CSs), autologous whole blood, platelet-rich plasma (PRP), extracorporeal shockwave therapy (ESWT), ultrasound therapy (US), botulinum toxin A (BTX-A), and dry needling (DN). Published prospective or randomized controlled trials (RCTs) as for the above eight therapies were identified by searching CNKI, PubMed, and Embase. Mean difference (MD) and 95% credible intervals (CrIs) of visual analogue scale (VAS) were used to evaluate multiaspect comparisons. The ranking result was obtained by utilizing surface under cumulative ranking curve (SUCRA). Node-splitting plots were conducted to assess the consistency between direct and indirect evidence. Egger's test and funnel plots were performed to examine publication bias. Forty-one trials with a total of 2,889 cases were involved in this NMA. In terms of 1-month VAS, only ESWT turned out to be of better efficacy than placebo (MD = -3.3; CrI: [-5.3, -1.1]). No statistically significant difference was found between pair-wise comparisons concerning 2-month VAS. ESWT also demonstrated better efficacy as for 3-month results (MD = -2.7; CrI: [-4.2, -1.3]). Besides, CSs was significantly better than placebo as well in 3-month results (MD = -2.1; CrI: [-4.1, -0.19]). With regard to 6-month VAS results, ESWT performed better than placebo (MD = -3.0; CrI: [-5.0, -0.51]). According to the SUCRA, ESWT ranked the first as for all seven outcomes. ESWT might be the optimal treatment. In addition, BTX-A and PRP were considered as suboptimal.

show abstract

Chronic Plantar Fasciitis Treated with Two Sessions of Radial Extracorporeal Shock Wave Therapy

Abstract: RSWT was successful in the treatment of chronic PF even when only two sessions with 2,000 impulses each were performed 1 week apart.

Cited by 77 publications

References 22 publications

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

Extracorporeal Shock Wave Therapy Is Effective In Treating Chronic Plantar Fasciitis: A Meta-analysis of RCTs

An Evaluation of the Efficacy of ESWT and Placebo-ESWT Treatment for Chronic Plantar Fasciitis

Comparison of efficacy of eight treatments for plantar fasciitis: A network meta‐analysis

Contact Info

Product

Resources

About